SCHEMBL188983

SCHEMBL188983

NCCOc1[c]cccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
TAAR1 Q96RJ0 1/20 0.48
LTA4H P09960 2/20 0.42
PLA2G2A P14555 1/20 0.42
HTR1B P28222 1/20 0.40
MAPK1 P28482 2/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 2/20 0.37
CYP3A4 P08684 2/20 0.35
MEN1 O00255 1/20 0.35
TRPM2 O94759 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4793877 0.90 HTR1B (0.42) KDM4ETAAR1LTA4HPLA2G2AHTR1B
SCHEMBL5256020 0.88 HTR1B (0.37) KDM4ETAAR1HTR1B
SCHEMBL6238419 0.87 JAK2 (0.33) KDM4ETAAR1MAPK1SMN1; SMN2HPGD
SCHEMBL2008537 0.83 KCNH2 (0.32) KDM4ETAAR1ALDH1A1
SCHEMBL5253475 0.83
SCHEMBL8217123 0.82 KMT2A (0.33) KDM4EMEN1KMT2A
SCHEMBL126227 0.79 ALDH1A1 (0.34) KDM4ELTA4HMAPK1TP53RAB9A
SCHEMBL2458787 0.79
SCHEMBL8583545 0.79
SCHEMBL348920 0.79 ALDH1A1 (0.48) SMN1; SMN2CYP3A4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103664637-A Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders ACUCELA INC 2014-03-26 CN claimed
CN-101784188-A Alkynyl phenyl derivative compounds for the treatment of ophthalmic diseases and disorders ACUCELA INC 2010-07-21 CN claimed
EP-0958294-A1 2-(1,2,4-TRIAZOLE-1-YL)-1,3,4-THIADIAZOLE DERIVATIVES HAVING AN EFFECT ON THE C.N.S. AND THE HEART EGIS GYOGYSZERGYAR (HU) 1999-11-24 EP claimed
WO-1998030561-A1 2-(1,2,4-TRIAZOLE-1-YL)-1,3,4-THIADIAZOLE DERIVATIVES HAVING AN EFFECT ON THE C.N.S. AND THE HEART EGIS Gyógyszergyár Rt. (HU) 1998-07-16 WO claimed
EP-0282127-B1 Beta-aminoethyl-substituted phenyl compounds, and anti-inflammatory or analgesic compositions containing them PROCTER & GAMBLE (US) 1994-02-02 EP claimed
US-5099030-A Phenols or phenolic ethers THE PROCTER & GAMBLE COMPANY (US) 1992-03-24 US claimed
EP-0282127-A2 Beta-aminoethyl-substituted phenyl compounds, and anti-inflammatory or analgesic compositions containing them THE PROCTER & GAMBLE COMPANY (US) 1988-09-14 EP claimed
EP-0058890-B1 ANTITHROMBOTIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1984-09-26 EP claimed
EP-0058890-A1 Antithrombotic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1982-09-01 EP claimed
CN-115960032-A Aryloxy propanol amine beta-adrenaline receptor ligand with beta-arrestin biased agonistic activity and application thereof 复旦大学 2023-04-14 CN disclosed
CN-105541769-A Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders ACUCELA INC 2016-05-04 CN disclosed
CN-103664637-B Be used for the treatment of ophthalmic diseases and disorderly alkynyl phenyl derivative compounds ACUCELA INC. (US) 2016-02-03 CN disclosed
CN-105189506-A Compounds and compositions for the treatment of parasitic diseases NOVARTIS AG 2015-12-23 CN disclosed
CN-105101970-A Beta-lactamase inhibitors VENATORX PHARMACEUTICALS INC 2015-11-25 CN disclosed
EP-0260066-B1 TAMOXIFEN DERIVATIVES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-05-09 EP disclosed
US-4839155-A Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1989-06-13 US disclosed
EP-0282127-A2 Beta-aminoethyl-substituted phenyl compounds, and anti-inflammatory or analgesic compositions containing them THE PROCTER & GAMBLE COMPANY (US) 1988-09-14 EP disclosed
EP-0260066-A1 Tamoxifen derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1988-03-16 EP disclosed
EP-0058890-B1 ANTITHROMBOTIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1984-09-26 EP disclosed
EP-0058890-A1 Antithrombotic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1982-09-01 EP disclosed